Sign Up
bf/NASDAQ:LEGN_icon.jpeg

COM:LEGENDBIOTECH

Legend Biotech

  • Stock

Last Close

40.14

21/11 21:00

Market Cap

8.63B

Beta: -

Volume Today

1.76M

Avg: -

OverviewAnalysisMetricsFinancialsFilingspeopleAPIChartData
Income StatementBalance SheetCash FlowKey MetricsRatios
Quarterly
Yearly

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
asset turnover
0.11
-
0.20
73.80%
0.10
47.26%
0.08
23.50%
0.09
9.49%
0.15
75.46%
cash conversion cycle
-125.58
-
199.44
258.81%
cash per share
2.16
-
1.59
26.49%
4.28
169.88%
6.26
46.37%
6.45
2.94%
7.43
15.28%
company equity multiplier
49.61
-
-2.34
104.72%
2.57
209.87%
2.37
7.75%
1.79
24.66%
1.48
17.39%
days of inventory outstanding
57.82
-
43.08
25.50%
days of payables outstanding
183.68
-
44.69
75.67%
days of sales outstanding
806.53
-
227.91
71.74%
409.90
79.85%
256.76
37.36%
0.28
99.89%
201.05
71,508.99%
dividend yield
ebit per revenue
-0.03
-
-2.29
7,219.98%
-4.14
81.18%
-4.38
5.71%
-3.90
11.00%
-1.55
60.19%
ebt per ebit
1.05
-
1.00
5.44%
0.98
1.45%
0.98
0.09%
0.98
0.49%
1.18
20.28%
effective tax rate
-0.72
-
-0.02
97.24%
0.01
167.51%
-0.00
100.02%
-0.00
54,054.59%
0.00
355.58%
enterprise value multiple
-487.95
-
-28.90
94.08%
-9.48
67.22%
-15.82
67.01%
-17.00
7.45%
-22.87
34.50%
fixed asset turnover
1.48
-
0.76
48.84%
0.62
17.80%
0.58
7.17%
0.72
24.99%
1.50
107.72%
free cash flow per share
2.86
-
-1.22
142.64%
-2.31
89.28%
-1.74
24.48%
-1.40
19.83%
-2.87
105.58%
gross profit margin
1
-
1
0%
1
0%
1
0%
0.44
55.86%
0.42
4.27%
interest coverage
-18.71
-
-586.87
3,037.09%
-74.45
87.31%
-436.69
486.59%
-42.22
90.33%
-20.29
51.94%
inventory turnover
6.31
-
8.47
34.23%
long term debt to capitalization
0.31
-
-0.04
113.71%
0.01
115.76%
0.21
2,940.92%
0.27
33.20%
0.18
33.02%
net income per ebt
1.72
-
1.02
40.80%
0.99
3.28%
1.00
1.37%
1.00
0.14%
1.00
0.50%
net profit margin
-0.06
-
-2.32
3,998.10%
-4.01
72.70%
-4.30
7.25%
-3.81
11.31%
-1.82
52.36%
operating cash flow per share
3.07
-
-0.83
127.00%
-1.89
127.71%
-1.41
25.35%
-1.26
10.74%
-2.18
73.60%
operating cycle
58.10
-
244.12
320.18%
operating profit margin
-0.03
-
-2.29
7,219.98%
-4.14
81.18%
-4.38
5.71%
-3.90
11.00%
-1.55
60.19%
payables turnover
1.99
-
8.17
311.04%
pretax profit margin
-0.03
-
-2.28
6,821.94%
-4.06
78.55%
-4.30
5.81%
-3.81
11.43%
-1.82
52.12%
price fair value
428.70
-
-30.18
107.04%
11.87
139.34%
13.93
17.36%
10.67
23.44%
8.47
20.63%
receivables turnover
0.45
-
1.60
253.87%
0.89
44.40%
1.42
59.64%
1.30K
91,352.14%
1.82
99.86%
return on assets
-0.01
-
-0.46
7,022.51%
-0.42
8.93%
-0.35
17.96%
-0.34
2.89%
-0.28
16.40%
return on capital employed
-0.01
-
-0.82
14,293.44%
-0.56
31.59%
-0.47
16.22%
-0.44
5.92%
-0.27
38.59%
return on equity
-0.32
-
1.08
436.21%
-1.08
200.06%
-0.82
24.31%
-0.60
26.83%
-0.41
30.94%
total debt to capitalization
0.33
-
-0.05
115.65%
0.01
122.82%
0.21
1,640.23%
0.28
33.63%
0.19
33.02%

All numbers in (except ratios and percentages)